Close Menu

Cedric Loiret-Bernal has become the president and CEO of Nanolink, a Chicago-based company that makes nanofabricated devices. Loire-Bernal was previously CEO of Geneva Proteomics, which he co-founded. He most recently held a position at CDP Capital Technology Ventures, a Canadian investment company. Prior to founding GeneProt, Loiret-Bernal was a partner and senior investment analyst at Brinson Partners, now part of UBS. He holds a medical degree from the University of Bordeaux and an MBA from Northwestern University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.